Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

MSDS

Search for MSDS (Material Safety Data Sheet) by Product Number

RNAi Learning Center

MISSION® RNAi Resources

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contact Us

Contact Cutomer Service

New Email Subscription Center

To receive the information that is relevant to your work, explore our new subscription center and set your preferences

Global Citizenship

Learn more about our commitment to people, green chemistry and the environment

Interactive Periodic Table

The table offers an easy way to access Aldrich Materials Science products

Advanced Structure Search

Copy and paste, advanced query features, instant structure to name generation, element analysis and more

News & Information

St. Louis, MO - March 20, 2015 Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of Aldrichimica Acta

Company's top-ranked chemical review journal to feature commentary from thought leaders in green chemistry

Sigma-Aldrich Corporation (NASDAQ: SIAL) today launched the next phase of its global green chemistry initiative. The program, which aims to reduce the chemical-related impact on human health and the environment, kicks off with the first-ever "green" issue of the Company’s chemical review journal Aldrichimica Acta.

Read More
St. Louis, MO - March 19, 2015 Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche

Provides Researchers with Global Access to Roche Biochemical Reagents Product Portfolio

Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today it signed an exclusive global distribution agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY). The agreement pairs Roche's high-quality Biochemical Reagents product portfolio with the industry-leading eCommerce and supply chain capabilities of Sigma-Aldrich.

Read More
St. Louis, MO - March 11, 2015 China's BeiGene Selects SAFC CHOZN® Platform for Commercial Drug Development

Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has entered a commercial sales and service contract with leading biopharmaceutical company, BeiGene (www.beigene.com). Located in Beijing, the innovative oncology company purchased SAFC’s off-the-shelf, turnkey CHOZN cell line production platform and cell line engineering services to support discovery and commercial development of BeiGene’s targeted oncology drug.

Read More
St. Louis, MO - February 24, 2015 Cerilliant Introduces Certified Spiking Solutions® of Tryptamines

Sigma-Aldrich Corporation (NASDAQ: SIAL) is pleased to announce that the Cerilliant® brand within its Applied Diagnostics and Testing business is introducing  eight new Certified Spiking Solutions® of tryptamines for use in quantitative mass spec-based testing applications such as forensic analysis, clinical toxicology, urine drug testing, or pharmaceutical research. This product introduction includes solution CRMs for five synthetic tryptamines 5-MeO-AMT, 5-MeO-DALT, 5-MeO-MiPT, 5-MeO-DMT, and 5-MeO-DiPT in addition to three naturally occurring tryptamines N, N-dimethyltryptamine; psilocybin; and its stable-labeled internal standard.

Read More